JENNIFER VOGT: Open Payments
NPI 1770918369 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 40 payments from 17 companies in 2025. Trend: 2023 $907 · 2024 $1,152 · 2025 $1,408
Food & beverage: $1,408
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $275 |
| Novo Nordisk Inc | 9 | $229 |
| BridgeBio Pharma, Inc. | 4 | $176 |
| Novartis Pharmaceuticals Corporation | 1 | $127 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Merck Sharp & Dohme LLC | 4 | $72 |
| ABIOMED | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Boston Scientific Corporation | 1 | $36 |
Products named: REPATHA, Wegovy, Attruby, LEQVIO, AMVUTTRA, UPTRAVI, VERQUVO, EVKEEZA.
Industry payments across NJ — which companies pay providers there.
